CYP2B6*6 is an independent determinant of inferior response to fludarabine plus cyclophosphamide in chronic lymphocytic leukemia


Autoria(s): Johnson, G.G.; Lin, K.; Cox, T.F.; Oates, M.; Sibson, D.R.; Eccles, R.; Lloyd, B.; Gardiner, L-J.; Carr, D.F.; Pirmohamed, M.; Strefford, J.C.; Oscier, D.G.; de Castro, D.G.; Else, M.; Catovsky, D.; Pettitt, A.R.
Data(s)

19/12/2013

Identificador

http://pure.qub.ac.uk/portal/en/publications/cyp2b66-is-an-independent-determinant-of-inferior-response-to-fludarabine-plus-cyclophosphamide-in-chronic-lymphocytic-leukemia(effe6981-57b3-430a-982d-f36a971c8319).html

http://dx.doi.org/10.1182/blood-2013-07-516666

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Johnson , G G , Lin , K , Cox , T F , Oates , M , Sibson , D R , Eccles , R , Lloyd , B , Gardiner , L-J , Carr , D F , Pirmohamed , M , Strefford , J C , Oscier , D G , de Castro , D G , Else , M , Catovsky , D & Pettitt , A R 2013 , ' CYP2B6*6 is an independent determinant of inferior response to fludarabine plus cyclophosphamide in chronic lymphocytic leukemia ' Blood , vol 122 , no. 26 , pp. 4253-4258 . DOI: 10.1182/blood-2013-07-516666

Tipo

article